Trelagliptin succinate
    Nintedanib ethanesulfonate
    Eltrombopag Olamine
    Abiraterone acetate
    Ulipristal acetate

    Melitracen hydrochloride Intermediates
    Selexipag intermediates
    LCZ696 Intermediates
    Ezetimibe intermediates
    Trelagliptin succinate intermediates
    Omarigliptin intermediates
Media Center
Authorized Patent of Synthesis of Dronedarone hydrochloride
The third Patent application of the project of Abiraterone acetate
Patent applied of Method of Purification of Abiraterone
New process of synthesis of abiraterone acetate(CAS 154229-18-2), patent applied
Dr. Fu is in Sichuan 2011 "Hundred Talents" Plan
Patent Application of Key Intermediate of Ulipristal Acetate
"Excellent Start-ups"
Start-up Support Programs for Returned Oversea Students 2010
Fund for Merit-based Projects of Returned Oversea Students Technology Projects 2010
Research of new process of synthesis of key intermediate of Dronedarone
About Us
Chengdu D-Innovation Pharmaceutical Co., Ltd is a professional company engaging in the research, development and manufacturing of API and Intermediates. We have a senior technical team with extremely rich experiences in the field of R&D of new products of API and Intermediates. Our primary objective is to improving and optimizing the processes of API and Intermediates.
We aim to be an enterprise of double-innovation of technology. Our main products now are Abiraterone Acetate, Abiraterone Acetate intermediates, Uliprisnil acetate, Uliprisnil acetate intermediates, CDB2914, CDB2914 intermediates , Lacosamide, lacosamide Intermediates, minodronic acid, minodronic Intermediates.

Copyright © 2011, Chengdu D-innovation Pharmaceutical Co., Ltd. Supported by